SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-10-002674
Filing Date
2010-03-24
Accepted
2010-03-24 16:21:45
Documents
6
Period of Report
2010-04-27
Effectiveness Date
2010-03-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2197425zdef14a.htm DEF 14A 803031
2 G817752.JPG g817752.jpg GRAPHIC 6750
3 G979546.JPG g979546.jpg GRAPHIC 3974
4 G352051.JPG g352051.jpg GRAPHIC 6598
5 G363542BGI001.GIF g363542bgi001.gif GRAPHIC 79751
6 G363542BGI002.GIF g363542bgi002.gif GRAPHIC 79852
  Complete submission text file 0001047469-10-002674.txt   1049059
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 10702038
SIC: 2834 Pharmaceutical Preparations